» Articles » PMID: 11120926

Increased Activated Human T Cell Lymphotropic Virus Type I (HTLV-I) Tax11-19-specific Memory and Effector CD8+ Cells in Patients with HTLV-I-associated Myelopathy/tropical Spastic Paraparesis: Correlation with HTLV-I Provirus Load

Overview
Journal J Infect Dis
Date 2000 Dec 20
PMID 11120926
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

To discern the T cell subtype associated with T cell differentiation, the expression of CD45RA and CD27 was measured from total CD8(high) cells and from human T cell lymphotropic virus type I (HTLV-I) Tax11-19 peptide-specific CD8(+) cells in peripheral blood lymphocytes of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Phenotypically defined memory and/or effector cells (CD45RA(-)CD27(+), CD45RA(+)CD27(-), and CD45RA(-)CD27(-)) were increased in HAM/TSP CD8(+) cells, compared with those of HTLV-I-seronegative healthy control subjects. The percentage of human leukocyte antigen (HLA)-DR-positive cells was also increased in CD8(+) cells of HAM/TSP, compared with those in HLA-DR(+)CD8(+) cells of healthy control subjects. HTLV-I provirus load correlated with the frequency of Tax11-19-specific CD8(+) cells. The high frequency of memory and/or effector type HTLV-I Tax11-19-specific CD8(+) cells suggests that continuous restimulation driven by HTLV-I antigens in vivo may be associated with the pathogenesis of HAM/TSP.

Citing Articles

B-cell depletion limits HTLV-1-infected T-cell expansion and ameliorate HTLV-1-associated myelopathy.

Lv A, Fang Y, Lin X, Chen J, Song H, Wang N Ann Clin Transl Neurol. 2024; 11(10):2756-2768.

PMID: 39186315 PMC: 11514899. DOI: 10.1002/acn3.52190.


T cell receptor repertoire analysis in HTLV-1-associated diseases.

Clauze A, Enose-Akahata Y, Jacobson S Front Immunol. 2022; 13:984274.

PMID: 36189294 PMC: 9520328. DOI: 10.3389/fimmu.2022.984274.


Evaluation of interleukin-32 and cyclooxygenase-2 expression in HAM/TSP patients and HTLV-1 asymptomatic carriers.

Hatatian N, Bosstani R, Mohammadi A, Mehraban S, Mahdifar M, Zemorshidi F Iran J Basic Med Sci. 2021; 24(7):992-996.

PMID: 34712431 PMC: 8528256. DOI: 10.22038/ijbms.2021.50821.11569.


Pathogenesis of HTLV-1 infection and progression biomarkers: An overview.

Brites C, Grassi M, Quaresma J, Ishak R, Vallinoto A Braz J Infect Dis. 2021; 25(3):101594.

PMID: 34256025 PMC: 9392164. DOI: 10.1016/j.bjid.2021.101594.


Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection.

Clements D, Crumley B, Chew G, Davis E, Bruhn R, Murphy E Front Immunol. 2021; 12:608890.

PMID: 33767694 PMC: 7985073. DOI: 10.3389/fimmu.2021.608890.